Clinical Study

Bxq-350

Posted Date: May 15, 2019

  • Investigator: John Morris
  • Specialties: Cancer, Oncology
  • Type of Study: Drug

The purpose of this study is to test the safety of BXQ-350, an investigational drug, at different doses to find out what effects, if any, it has on people with cancer. An investigational drug means the drug is being tested and is not approved for sale by the regulatory authorities.

Criteria:

To Be Eligible: Must Have Advanced Solid Tumor Cancer Or High Grade Glioma, Age 18 Or Older, Nonpregnant/Breastfeeding, No Other Malignancy Within 1 Year, No Severe Infections

Keywords:

Glioma, Advanced, Tumor, Cancer, Phase I

For More Information:

Uc Cancer Institute
513-584-7698
cancer@uchealth.com


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.